Methylphenidate in Treatment of ADHD and Comorbid Chronic Tic Disorder

Abstract

The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention deficit hyperactivity disorder (ADHD) in children (ages 6-12 years) with Tourette's syndrome (96%) or chronic motor tic disorder (4%) were evaluated at State University of New York, Stony Brook.

Keywords

• immediate-release methylphenidate
• attention deficit hyperactivity disorder
• chronic tic disorder